Xeris Biopharma Holdings (0A8E.L) Stock Price
$7.61 3.3%
to add to portfolio
AI Score

-
Alternative
7 -
Fundamental
2 -
Technical
6
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Xeris Biopharma Holdings, AI stock picks, stock alerts and much more.
0A8E.L AI Stock Analysis
AI stock analysis for 0A8E.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Xeris Biopharma Holdings (0A8E.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Xeris Biopharma Holdings (0A8E.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Xeris Biopharma Holdings (0A8E.L), currently trading at $7.61, will... Sign up to access price prediction.
About 0A8E.L

-
Xeris Biopharma Holdings, Inc.
-
Symbol
0A8E.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
1.2B
Similar Stocks
![]() |
Codexis 0I0X.L |
$2.43 0.5% |
5 |
![]() |
Oxford Nanopore Technologies plc ONT.L |
£162.3 3% |
6 |
![]() |
Sareum Holdings SAR.L |
£27.5 7.8% |
6 |
![]() |
Viridian Therapeutics 0K1R.L |
$18.71 0.4% |
5 |
![]() |
Avacta Group Plc AVCT.L |
£52 1% |
3 |
News
0A8E.L Alternative Data
Web Traffic
Xeris Biopharma Holdings receives an estimated 9559 monthly visitors to xerispharma.com.
-
Web Traffic
9559
-
Change from Previous Month
1.3%
-
3 Month Change
50.2%
-
YoY Change
50.2%
Facebook Engagement
Xeris Biopharma Holdings has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
-
YoY Change
100%
Job Postings
Xeris Biopharma Holdings has an estimated 47 open job postings, which is down -16.1% over the last month.
-
Job Postings
47
-
Daily Change
2.1%
-
1 Month Change
16.1%
-
3 Month Change
135%
-
YoY Change
135%
Reddit Mentions
Xeris Biopharma Holdings has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Xeris Biopharma Holdings has 981 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.
-
Twitter Followers
981
-
Daily Change
0.1%
-
1 Month Change
0.3%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Instagram Followers
Xeris Biopharma Holdings has 869 Instagram Followers on its main Instagram account, up by 3.1% over the last month.
-
Instagram Followers
869
-
Daily Change
0.2%
-
1 Month Change
3.1%
-
3 Month Change
6.1%
-
YoY Change
6.1%
LinkedIn Followers
28,010 are following Xeris Biopharma Holdings on LinkedIn, up by 8.6% over the last month.
-
LinkedIn Followers
28010
-
Daily Change
8.6%
-
1 Month Change
8.6%
-
3 Month Change
17.7%
-
YoY Change
17.7%
LinkedIn Employees
According to LinkedIn, Xeris Biopharma Holdings has 410 employees, down by -1.2% over the last month.
-
LinkedIn Employees
410
-
Daily Change
1.2%
-
1 Month Change
1.2%
-
3 Month Change
2.1%
-
YoY Change
2.1%
Business Outlook
According to employee reviews, the business outlook among employees at Xeris Biopharma Holdings is 63 out of 100 (bullish).
-
Business Outlook
63
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Xeris Biopharma Holdings was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0A8E.L Financials
0A8E.L Key Metrics
-
Total Revenue
$60.1M
-
Net Income
-$5.1M
-
Earnings per Share
-$0.0343
-
Free cash flow
$1.8M
-
EBITDA
$5.7M
-
EBITDA Ratio
0.0952262
-
Total Assets
$323.1M
0A8E.L 2-year Revenue & Income
0A8E.L 2-year Free Cash Flow
0A8E.L Technicals
0A8E.L SMA
0A8E.L RSI
FAQ
What's the current price of Xeris Biopharma Holdings (0A8E.L) Stock?
The price of an Xeris Biopharma Holdings (0A8E.L) share is $7.61.
What's the market cap of Xeris Biopharma Holdings?
The current market cap of Xeris Biopharma Holdings is 1.2B.
What are some stocks similar to Xeris Biopharma Holdings (0A8E.L) that investors often compare it to?
Xeris Biopharma Holdings (0A8E.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for Xeris Biopharma Holdings' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Xeris Biopharma Holdings' stock price to be around $7.93 in 2026. Starting from the current price of $7.61, this represents a 4.3% change in price, indicating a neutral outlook for the stock.
How to buy Xeris Biopharma Holdings (0A8E.L) Stock?
Xeris Biopharma Holdings stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Xeris Biopharma Holdings shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.